Making vaccines against African Swine Fever virus

Dr Linda Dixon of The Pirbright Institute describes the process of making vaccines against African swine fever virus (ASFV).

African swine fever virus (ASFV) causes a haemorrhagic fever in domestic pigs and wild boar resulting in mortality rates up to to 100%. In contrast, the 'wild' hosts in E Africa - warthogs and bushpigs can be persistently infected with few clinical signs. 

ASF is endemic in sub-Saharan Africa and Sardinia, and since 2007 has spread through the Trans-Caucasus, Russian Federation and into Eastern Europe. The disease has a huge impact socially and economically, posing a threat to global food security. The lack of a vaccine limits options for disease control.

You can look around The Pirbright Institute in our 360 tour here:

Last edited: 29 March 2022 14:32

Get the latest articles and news from Understanding Animal Research in your email inbox every month.
For more information, please see our privacy policy.